Improved Boron Neutron Capture Therapy Using Integrin αvβ3-Targeted Long-Retention-Type Boron Carrier in a F98 Rat Glioma Model

SIMPLE SUMMARY: The development of a novel boron carrier is a key step in clinical boron neutron capture therapy (BNCT). We previously reported that maleimide-functionalized closo-dodecaborate albumin conjugate (MID-AC) with albumin as the drug delivery system is an effective boron carrier for the F...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsujino, Kohei, Kashiwagi, Hideki, Nishimura, Kai, Kayama, Ryo, Yoshimura, Kohei, Fukuo, Yusuke, Shiba, Hiroyuki, Hiramatsu, Ryo, Nonoguchi, Naosuke, Furuse, Motomasa, Takami, Toshihiro, Miyatake, Shin-Ichi, Hu, Naonori, Takata, Takushi, Tanaka, Hiroki, Suzuki, Minoru, Kawabata, Shinji, Nakamura, Hiroyuki, Wanibuchi, Masahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045558/
https://www.ncbi.nlm.nih.gov/pubmed/36979069
http://dx.doi.org/10.3390/biology12030377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045558/
https://www.ncbi.nlm.nih.gov/pubmed/36979069
http://dx.doi.org/10.3390/biology12030377

Ejemplares similares